Skip to content

Donaldson Company DCI Life Sciences Segment — Purchase price adjustments

Discontinued — last reported Q1 '24

Similar metrics at other companies

Agilent Technologies logo
ALife Sciencesand Applied Markets — Goodwill Adjustments
$1M-66.7%
Leidos Holdings logo
LDOSHealth — Acquisition of business, purchase accounting adjustment
$0
IDEX logo
IEXHealth & Science Technologies — Acquisition adjustments
$0-100%
Zebra Technologies logo
ZBRAAIT — Purchase price allocation adjustments
$0
Element Solutions logo
ESIIndustrial & Specialty — Purchase accounting adjustments
$0
Corpay logo
CPAYOther — Acquisition Accounting Adjustments
$0

Other financials

Income statement

See full
Revenue$995.1M+5.9%
Gross profit$333.4M+3.6%
Operating income$155.3M+77.7%
Net income$118.1M+104%
EPS (diluted)$1.00+108%

Balance sheet

See full
Cash & equivalents$204.1M+14.3%
Total debt$601.9M-16.7%
Total equity$1.7B+15.8%
Total assets$3.1B+3.0%

Cash flow

See full
Operating cash flow$135.4M+54.4%
CapEx$23.3M+42.9%
Free cash flow$112.1M+57.0%

Valuation

See full
Market cap$9.91B+29.8%
Enterprise value$10.31B+26.2%
P/E22.6×+1.5×
P/S2.6×+0.5×

Profitability

See full
Gross margin34.2%-1.0pp
Operating margin15.1%+1.7pp
Net margin11.5%+1.6pp
FCF margin10.3%+2.1pp

Returns & leverage

See full
Return on equity27.8%+3.2pp
Debt / equity0.4×-0.1×
Current ratio2.4×+0.4×

Where this comes from

Reported directly by Donaldson Company in its filing.

Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.

The official record: Donaldson Company’s 10-Q, filed December 6, 2023, on SEC EDGAR. View the filing →

Ask your AI about Donaldson Company's life sciences segment — purchase price adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Donaldson Company's life sciences segment — purchase price adjustments?
Donaldson Company (DCI) reported life sciences segment — purchase price adjustments of -$1.1M in Q3 2023.
What does life sciences segment — purchase price adjustments mean?
Accounting adjustments to the value of assets and liabilities following an acquisition in the Life Sciences segment.
How do you interpret life sciences segment — purchase price adjustments?
Negative adjustments often reflect the step-up in inventory costs that compress margins post-acquisition, while positive adjustments may reflect revisions to initial fair value estimates.
How does life sciences segment — purchase price adjustments compare across companies?
Standard in financial reporting under 'Purchase Price Allocation' or 'Acquisition Accounting Adjustments' for companies with active M&A pipelines.